Ergon Capital Partners has acquired French manufacturer and distributor of in vitro diagnostic equipment and reagents ELITech Group, in a deal that values the business at just over €100m.
This article is only available to subscribers to unquote.com. Subscribers just need to log in below for immediate access. Not a subscriber? Sign up now for immediate free trial access
Sign up
Free trial
Try unquote.com free for 2 weeks. A trial will give you access to the entire site.